NCT00091858View on ClinicalTrials.gov

Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer

PHASE3CompletedINTERVENTIONAL

Enrollment

1,000

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

October 31, 2006

Study Completion Date

December 31, 2006

Conditions

AnemiaCancer

Interventions

DRUG

Darbepoetin Alfa

6.75 mcg/kg Q4W

DRUG

Placebo

Placebo Q4W

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY